MacroGenics, Inc. (MGNX)
NMS – Real Time Price. Currency in USD
3.52
+0.57 (19.32%)
At close: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
3.52
+0.57 (19.32%)
At close: May 12, 2026, 4:00 PM EDT
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company’s product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule that targets an undisclosed antigen expressed across several solid tumors, which is in preclinical trials. It is also developing T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
| Name | Position |
|---|---|
| Dr. Ezio Bonvini M.D. | Senior VP of Research & Chief Scientific Officer |
| Dr. Frank George Perabo FEBU, M.D., Ph.D. | Vice President & Interim Head of Clinical Development |
| Dr. Thomas M. Spitznagel Ph.D. | Senior Vice President of Technical Operations |
| Mr. Eric Blasius Risser | CEO, President & Director |
| Mr. Harish Krishnaswamy | Senior Vice President of Business Development & Portfolio Planning |
| Mr. James Karrels | Senior VP, CFO & Corporate Secretary |
| Mr. Jeffrey Stuart Peters J.D. | Senior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer |
| Mr. Steve Harig | Senior Vice President of Human Resources |
| Ms. Beth Smith | VP, Controller & Treasurer |
| Date | Type | Document |
|---|---|---|
| 2026-05-12 | 8-K | mgnx-20260511.htm |
| 2026-05-04 | 8-K | mgnx-20260501.htm |
| 2026-04-22 | DEFA14A | defa14aamendment.htm |
| 2026-04-08 | 8-K | mgnx-20260408.htm |
| 2026-03-09 | 8-K | mgnx-20260309.htm |
| 2026-03-09 | 10-K | mgnx-20251231.htm |
| 2026-03-02 | 8-K | mgnx-20260302.htm |
| 2026-02-24 | 8-K | mgnx-20260223.htm |
| 2025-11-20 | 8-K | mgnx-20251114.htm |
| 2025-11-12 | 8-K | mgnx-20251112.htm |